高级检索
当前位置: 首页 > 详情页

Effects of Endoscopic Mucosa! Resection in Patients with Low-Grade Intraepithelial Dysplasia of Esophageal Squamous Cells

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Shandong Univ, Qilu Hosp, Tumor Ctr, Jinan 250012, Peoples R China [2]Shandong Univ Tradit Chinese Med, Affiliated Hosp 2, Jinan 250012, Peoples R China [3]Shandong Tumor Hosp & Inst, Jinan, Peoples R China [4]Shandong Acad Med Sci, Inst Basic Med, Jinan, Peoples R China [5]Feicheng Cty Peoples Hosp, Feicheng, Peoples R China [6]Capital Med Univ, Beijing Friendship Hosp, Dept Gastroenterol, Beijing, Peoples R China
出处:
ISSN:

关键词: Endoscopy Mucosal resection Low-grade intraepithelial dysplasia Esophagus

摘要:
Background: This study evaluated the effects of endoscopic mucosa! resection (EMR) on patients with low-grade intraepithelial dysplasia (LGD) of the esophageal squamous cells. Methods: A randomized study recruited 128 LGD patients. These patients were randomly divided into treatment and included 65 LGD cases that were not treated with EMR. Clinical interviews and endoscopy were conducted after 30 months as postoperative follow-up. Results: Concerning the percentages of esophageal lesions that changed from serious conditions into slight conditions (namely from high-grade intraepithelial dysplasia (HGD) to LGD, basal cell hyperplasia, esophagitis and normal mucosa) there was a significantly linear trend relationship between the treatment group and control group. In downstaging of dysplasia grade, the total percentage for the 52 cases (82.5%) in the treatment group was significantly higher than that for the 32 cases (49.2%) in the control group (Pearson X-2 = 15.734, p > 0.001). Also, in patients that remained at the LGD grade or had upstaging of their dysplasia grade, the proportions of the change were significantly different between the two groups. Condusion:The percentage rate of regression of LGD was increased in the EMR treatment group as compared to that of the control group. EMR may prevent or delay the progression of LGD to HGD. (G) 20135. Karger AG, Basel

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2012]版:
大类 | 4 区 医学
小类 | 4 区 胃肠肝病学 4 区 外科
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 胃肠肝病学 4 区 外科
JCR分区:
出版当年[2011]版:
Q3 SURGERY Q4 GASTROENTEROLOGY & HEPATOLOGY
最新[2023]版:
Q2 SURGERY Q3 GASTROENTEROLOGY & HEPATOLOGY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2011版] 出版当年五年平均[2007-2011] 出版前一年[2010版] 出版后一年[2012版]

第一作者:
第一作者单位: [1]Shandong Univ, Qilu Hosp, Tumor Ctr, Jinan 250012, Peoples R China [*1]Shandong Univ, Qilu Hosp, 107 Wenhuaxi Rd, Jinan 250012, Peoples R China
通讯作者:
通讯机构: [1]Shandong Univ, Qilu Hosp, Tumor Ctr, Jinan 250012, Peoples R China [*1]Shandong Univ, Qilu Hosp, 107 Wenhuaxi Rd, Jinan 250012, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)